A Multiple Ascending Dose (MAD) Study of R547 Administered as an Intravenous Infusion on a Weekly Schedule in Patients With Advanced Solid Tumors
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
AEs, laboratory parameters.
United States: Food and Drug Administration
|Austin, Texas 78705|
|Hackensack, New Jersey 07601|
|Charlotte, North Carolina|